Business Wire

CA-DENODO

9.6.2022 09:02:06 CEST | Business Wire | Press release

Share
Denodo’s Sixth Annual Cloud Survey Finds Organizations Concerned About Managing New Cloud Systems When Attempting to Make the Best Use of Their Data

Denodo , a leader in data management, today released the findings of its sixth annual cloud usage survey which revealed that cloud adoption is continuing its rapid climb, with more than half (54%) of participants stating they are either at an intermediate or advanced level of cloud usage. Cloud-enabled business transformation has become a priority as organizations face global supply chain issues, cybersecurity threats, and geopolitical instability. While organizations of all sizes and vertical markets are turning to the cloud to ensure flexibility and resilience in the face of these challenges, small to medium sized businesses have driven investment in cloud infrastructure services to support workload migration, data storage services, and cloud-native application development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607006385/en/

Download the complimentary findings here .

Cloud-based data warehouses, data lakes, and lake houses played a prominent role in 2021, and was cited as both a top initiative by respondents (48%) and a top use case (57%). Hybrid cloud continues to be the deployment model of choice as it has been since the 2020 survey. However, this year, the gap between hybrid cloud and private cloud is dramatically wider. Hybrid cloud was chosen by almost twice the number of respondents (37.5%), compared with pure public cloud, at 20%. This year, it is clear that hybrid cloud is less a “choice” but a “necessity” and indicates that companies are not completely getting rid of their on-premises systems even if they have increased their cloud footprint. Companies have good reasons for deploying this mixed deployment style, regulatory compliance among them, which may be why they are opting not to simply abandon on-premises systems when the technology landscape changes.

As it relates to these survey respondent companies being data-driven, nearly four in five respondents (79%) cited complexity of data integration, data accessibility, and accommodating different data formats as the primary barrier to becoming data-driven followed by the lack of analytical skills and resources to turn raw data into insights (62%). Data scientists struggled as well. Often cited for spending more time finding, accessing, and preparing data than they do analyzing it, more than 2 out of five (44%) were unable to find, access, and analyze half or more of their data after adopting cloud technologies and only 17% were able to leverage 75% or more of their data.

The role of IT in the cloud modernization journey has also changed. In 2020, the focus for tech professionals was choosing the appropriate cloud provider and managing the migration. But in 2021, these IT teams are more focused on receiving the training needed to take their organization’s cloud systems to the next level (as per 31.3% of survey respondents), while other activities such as selecting cloud provider and planning for cloud migrations still remain important. Companies are using cloud for various use cases with the most popular being reporting and dashboards, and self-service BI and ad-hoc analytics; however, respondents anticipate a shift to data virtualization, data preparation, data quality and blending in the future.

These use cases paint a vivid portrait of where many organizations are with respect to their cloud journeys. First, it reflects the fact that the business stakeholders within organizations are ready to get better use out of their data, and second, it shows that organizations are now looking to maximize their cloud systems with robust cloud-based repositories. Having migrated key workloads to the cloud, the next step for many companies is to find a place to store the new data they then begin to acquire. Modern data-management approaches like logical data fabric enable organizations to seamlessly accommodate legacy systems so that they can work in tandem with cloud systems.

“Audiences continue to express their need for real-time data so it is no surprise that availability, with regard to data integration, management, and analytics in the cloud, is not only ‘nice to have,’ but critical to becoming data-driven,” said Ravi Shankar, senior vice president and chief marketing officer of Denodo. “This is true across all configurations, but the reality is most organizations are unable to find, access, and analyze half or more of their data after adopting cloud technologies. That may be why the overwhelming majority of organizations (93%) stated that they were using, evaluating, or considering leveraging cloud-based data integration, management, and analytics including powerful technologies, such as data virtualization and logical data fabric to provide seamless, real-time access across both on-premises and cloud systems.”

When it comes to choosing cloud service providers, Microsoft Azure and Amazon Web Services (AWS) continue to dominate the market by a wide margin, but this year, AWS (44.6%) has jumped ahead of Azure (26.2%) with a substantial lead, after Azure has kept just ahead of AWS for two consecutive years. Google Cloud Platform (GCP) came in as a third most popular option (8%), according to the survey. In contrast, Alibaba showed a bump from 1.4% in 2021 to 3.6% this year.

Methodology:

The Denodo Global Cloud Survey 2022 surveyed stakeholders at over 150 organizations across 3 major global regions – North America, EMEA, and APAC – to understand where organizations are in their cloud adoption journeys. Surveys were fielded online to data and cloud professionals from various backgrounds and roles in March of 2022. The results from the Denodo Global Cloud Survey 2022 are available for download here .

Please Tweet: https://bit.ly/3Nt7uZ1

About Denodo

Denodo is a leader in data management. The award-winning Denodo Platform is the leading data integration, management, and delivery platform using a logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across large enterprises and mid-market companies in 30+ industries have received payback in less than 6 months. For more information, visit www.denodo.com or call +1 877 556 2531 / +44 (0) 20 7869 8053 / +65 6950 7489.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release

Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye